Neurohormonal and Echocardiographic Results After CorCap and Mitral Annuloplasty for Dilated Cardiomyopathy

Annals of Thoracic Surgery

Volumn 88, Issue 3, 2009, Pages 719-725

  Rubino, Antonio S ^a   Onorati, Francesco ^a   Santarpino, Giuseppe ^a   Pasceri, Eugenia ^a   Santarpia, Giuseppe ^a   Cristodoro, Lucia ^a   Serraino, Giuseppe Filiberto ^a   Renzulli, Attilio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; NEUROHORMONE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CARDIAC RESTRAINT DEVICE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DEVICE INFECTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HOSPITAL READMISSION; HUMAN; KIDNEY FAILURE; MALE; MEAN ARTERIAL PRESSURE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MORBIDITY; MULTIPLE ORGAN FAILURE; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SCORING SYSTEM; SHORT FORM 36; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNITED STATES;

AGED; CARDIOMYOPATHY, DILATED; COMBINED MODALITY THERAPY; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART VALVE PROSTHESIS; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POLYESTERS; POSTOPERATIVE COMPLICATIONS; SURGICAL MESH; VENTRICULAR DYSFUNCTION, LEFT;

EID: 68849125201     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2009.05.050     Document Type: Article

References (31)

1. Oz M.C. Surgical issues in heart failure: what's new?. J Card Fail 7 suppl 1 (2001) 18-24
2. Kono T., Sabbah H.N., Rosman H., Alam M., Jafri S., and Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 20 (1992) 1594-1598
3. Yiu S.F., Enriquez-Sarano M., Tribouilloy C., Seward J.B., and Tajik A.J. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation 102 (2000) 1400-1406
4. Burkhoff D. New heart failure therapy: the shape of things to come?. J Thorac Cardiovasc Surg 122 (2001) 421-423
5. McCarthy P.M., Takagaki M., Young J.B., et al. Device based change in left ventricular shape: a new concept for the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg 122 (2001) 482-490
6. Franco-Cereceda A., McCarthy P.M., Blackstone E., et al. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation?. J Thoracic Cardiovasc Surg 121 (2001) 879-893
7. Chaudhry P.A., Mishima T., Sharov V.G., et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Thorac Surg 70 (2000) 1275-1280
8. Power J.M., Raman J., Dornom A., et al. Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res 44 (1999) 549-555
9. Power J.M., Raman J., Byrne M.J., and Alferness C.A. Passive ventricular constraint is a trigger for a significant degree of reverse remodeling in an experimental model of degenerative heart failure and dilated cardiomyopathy. Circulation 102 suppl (2000) II501.10
10. Starling R.C., and Jessup M. Worldwide clinical experience with the CorCap cardiac support device. J Card Fail 10 6 suppl (2004) S225-S233
11. Olsson A., Bredin F., and Franco-Cereceda A. Echocardiographic findings using tissue velocity imaging following passive containment surgery with the Acorn CorCap cardiac support device. Eur J Cardiothorac Surg 28 (2005) 448-453
12. Oz M.C., Konertz W.F., Kleber F.X., et al. Global surgical experience with the Acorn cardiac support device. J Thorac Cardiovasc Surg 126 (2003) 983-991
13. Hosenpud J.D., Bennett L.E., Keck B.M., Fiol B., Boucek M.M., and Novick R.J. The Registry of the International Society for Heart and Lung Transplantation: eighteenth official report-2001. J Heart Lung Transplant 20 (2001) 805-815
14. Konertz W.F., Shapland J.E., Hotz H., et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation 104 suppl I (2001) I-270-5
15. Konertz W., Dushe S., Hotz H., et al. Safety and feasibility of a cardiac support device. J Card Surg 16 (2001) 113-117
16. Mann D.L., Acker M.A., Jessup M., Sabbah H.N., Starling R.C., and Kubo S.H. Clinical evaluation of the CorCap cardiac support device in patients with dilated cardiomyopathy. Ann Thorac Surg 84 (2007) 1226-1235
17. Randall C., Starling R.C., Jessup M., et al. Sustained benefits of the CorCap cardiac support device on left ventricular remodeling: three-year follow-up results from the Acorn Clinical Trial. Ann Thorac Surg 84 (2007) 1236-1242
18. Elami A. CorCap device in addition to mitral surgery in heart failure: is it truly beneficial?. J Thorac Cardiovasc Surg 133 (2007) 590
19. Onorati F., Renzulli A., De Feo M., et al. Perioperative enoximone infusion improves cardiac enzyme release after CABG. J Cardiothorac Vasc Anesth 18 (2004) 409-414
20. Pieske B. Reverse remodeling in heart failure-fact or fiction?. Eur Heart J 6 suppl D (2004) 55-78
21. Bax J.J., Braun J., Somer S.T., Klautz R., Holman E.R., and Versteegh M.I. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 110 suppl 2 (2004) II-104-8
22. Hung J., Papakostas L., Tahta S.A., Hardy B.G., Bollen B.A., and Duran C.M. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty. Continued LV remodelling as a moving target. Circulation 110 11 suppl 1 (2004) II-85-90
23. Borger M.A., Alam A., Murphy P.M., Doenst T., and David T.E. Chronic ischemic mitral regurgitation: repair, replace or rethink?. Ann Thorac Surg 81 (2006) 1153-1161
24. Magne J., Senechal M., Mathieu P., Dumesnil J.G., Dagenais F., and Pibarot P. Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 51 (2008) 1692-1701
25. Sabbah H.N. The cardiac support device and the Myosplint: treating heart failure by targeting left ventricular size and shape. Ann Thorac Surg 75 (2003) S13-S19
26. Sabbah H.N., and Goldstein S. Ventricular remodeling: consequences and therapy. Eur Heart J 14 (1993) 24-29
27. Tibayan F.A., Rodriguez F., Langer F., et al. Undersized mitral annuloplasty alters left ventricular shape during acute ischemic mitral regurgitation. Circulation 110 suppl II (2004) II-98-102
28. Blom A.S., Mukherjee R., Pilla J.J., et al. Cardiac support device modifies left ventricular geometry and myocardial structure after myocardial infarction. Circulation 112 (2005) 1274-1283
29. Collisons P.O., Barnes S.C., Gaze D.C., Galasko G., Lahiri A., and Senior R. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non cardiac dispnoea. Eur J Heart Fail 6 (2004) 63-70
30. Wiese S., Breyer T., Dragu A., et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 102 (2000) 3074-3079
31. Fielitz J., Hein S., Mitrovic V., et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol 37 (2001) 1443-1444